Jenny Robertson, Chief Legal Officer at Lexeo Therapeutics ($LXEO), sold shares on the open market five times over the past year, totaling about $40,600. Her most recent sale occurred on November 18, 2025. These sales rank her 10,590th among 11,678 insiders in our database by total value sold, well below the average of $8.6 million across about six transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 549 | $9.27 | 68,381.0000 | 72,987,327 | 0.80% | 0.00% |
| Oct. 15, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | A | Common Stock | 9900 | $0.00 | 72,456.0000 | 33,196,997 | 15.83% | 0.03% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 40 | $9.56 | 68,930.0000 | 33,196,997 | 0.06% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 3486 | $8.94 | 68,970.0000 | 33,196,997 | 4.81% | 0.01% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 542 | $4.67 | 62,556.0000 | 33,196,997 | 0.86% | 0.00% |
| May 16, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 521 | $2.77 | 63,098.0000 | 33,196,997 | 0.82% | 0.00% |
| March 14, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | A | Common Stock | 5720 | $2.61 | 63,619.0000 | 0 | 9.88% | 0.00% |
| Feb. 19, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal Officer | S | Common Stock | 2101 | $4.41 | 57,899.0000 | 0 | 3.50% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal & Admin Officer | A | Common Stock | 36250 | $0.00 | 60,000.0000 | 0 | 152.63% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal & Admin Officer | A | Stock Option (right to buy) | 72500 | $0.00 | 72,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal and Admin Officer | A | Stock Option (Right to Buy) | 142500 | $0.00 | 142,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Robertson Jenny | Chief Legal and Admin Officer | A | Common Stock | 23750 | $0.00 | 23,750.0000 | 0 | 9999.99% | 0.00% |